https://www.taxtmi.com/news?id=69807 The Union Budget 2026-27 launches Bio-Pharma Shakti, a five-year Rs 10,000 crore programme to position India as a global bio-pharmaceutical manufacturing hub by strengthening drug manufacturing, research, testing and regulation. Complementary measures include expansion of public health coverage under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (over 62 crore beneficiaries and 10 crore treatments) and large-scale digitisation of health records through the Ayushman Bharat Digital Mission (about 84.7 crore ABHA IDs), intended to attract investment and bolster healthcare sector growth. en-us Tue, 03 Feb 2026 14:01:03 +0530 Tue, 03 Feb 2026 14:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=69807 The Union Budget 2026-27 launches Bio-Pharma Shakti, a five-year Rs 10,000 crore programme to position India as a global bio-pharmaceutical manufacturing hub by strengthening drug manufacturing, research, testing and regulation. Complementary measures include expansion of public health coverage under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (over 62 crore beneficiaries and 10 crore treatments) and large-scale digitisation of health records through the Ayushman Bharat Digital Mission (about 84.7 crore ABHA IDs), intended to attract investment and bolster healthcare sector growth. News - Tue, 03 Feb 2026 14:01:03 +0530 https://www.taxtmi.com/news?id=69807